Wu M S, Lin Y W, Sheu J C, Wang H P, Wang J T, Shun C T, Lee W J, Wang T H, Lin J T
Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei.
Jpn J Cancer Res. 1996 Oct;87(10):1052-5. doi: 10.1111/j.1349-7006.1996.tb03109.x.
The multiple tumor suppressor 1 (MTS1) and 2 (MTS2) genes, located on chromosome 9p21, have been reported to be deleted or mutated in many malignant cell lines and in a high percentage of some primary carcinomas. To determine whether these genes are altered, and if so, what is the nature of the alterations, in human gastric adenocarcinoma, we investigated their frequency of mutation by Southern blotting, polymerase chain reaction (PCR) and direct sequencing in 55 patients. Furthermore, loss of heterozygosity (LOH) of chromosome 9p21 at the IFNA locus and D9S171 was assessed. Homozygous deletions of exon 1 of the MTS1 gene were identified in 5 of 55 (9.1%) primary tumors. No deletion of MTS2 gene was noted. LOH was observed in 7 (14.3%) of 49 informative cases (5 cases at IFNA locus, 2 cases at D9S171 and one case with combined LOH at D9S171 and homozygous deletion at exon 1 of MTS1). Direct sequencing of PCR products of the MTS1 and MTS2 gene did not reveal any point mutation in these 55 patients. These data indicate that alterations of the MTS1 and MTS2 genes are infrequently encountered. Additional studies of LOH with more microsatellite markers near 9p21 are mandatory to elucidate whether another tumor suppressor gene exists in the vicinity of MTS1 in primary gastric adenocarcinoma.
位于9号染色体p21区域的多肿瘤抑制基因1(MTS1)和2(MTS2),据报道在许多恶性细胞系及部分原发性癌中存在缺失或突变。为确定这些基因在人胃腺癌中是否发生改变,若发生改变,其改变的性质如何,我们采用Southern印迹法、聚合酶链反应(PCR)及直接测序法对55例患者进行了突变频率的研究。此外,还评估了IFNA位点和D9S171处9号染色体p21区域的杂合性缺失(LOH)情况。在55例原发性肿瘤中的5例(9.1%)中检测到MTS1基因外显子1的纯合缺失。未发现MTS2基因的缺失。在49例信息充分的病例中有7例(14.3%)观察到LOH(5例在IFNA位点,2例在D9S171,1例在D9S171处存在联合LOH且MTS1基因外显子1存在纯合缺失)。对这55例患者MTS1和MTS2基因的PCR产物进行直接测序未发现任何点突变。这些数据表明MTS1和MTS2基因的改变很少见。必须采用更多9号染色体p21区域附近的微卫星标记对LOH进行进一步研究,以阐明在原发性胃腺癌中MTS1附近是否存在另一个肿瘤抑制基因。